The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of sigma-1 agonist fluvoxamine on experimental induced tardive dyskinesia model in rats
Authors
Keywords
-
Journal
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 126, Issue -, Pages 110787
Publisher
Elsevier BV
Online
2023-05-23
DOI
10.1016/j.pnpbp.2023.110787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
- (2018) Janette Bester et al. CYTOKINE
- Reprint of: Clinical management of tardive dyskinesia: Five steps to success
- (2018) Leslie Citrome JOURNAL OF THE NEUROLOGICAL SCIENCES
- Activation of Sigma-1 Receptor by Cutamesine Attenuates Neuronal Apoptosis by Inhibiting Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in a Rat Model of Asphyxia Cardiac Arrest
- (2018) Jiahong Qin et al. SHOCK
- Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells
- (2014) Tamaki Ishima et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases
- (2014) Yakup Albayrak et al. Psychiatry Investigation
- Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
- (2012) Tomihisa Niitsu et al. CURRENT PHARMACEUTICAL DESIGN
- Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease
- (2012) P. Samadi et al. GENES BRAIN AND BEHAVIOR
- Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis
- (2012) James T. Teo et al. MOVEMENT DISORDERS
- Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development
- (2012) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders
- (2011) Karen M. Doyle et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Genome-Wide Identification of Bcl11b Gene Targets Reveals Role in Brain-Derived Neurotrophic Factor Signaling
- (2011) Bin Tang et al. PLoS One
- Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases
- (2010) Tsutomu Furuse et al. Annals of General Psychiatry
- Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways
- (2008) Tomoko Nishimura et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now